Site icon Market Globalist

How Come Ovid Therapeutics Is On The Rise Today?



Price of the biopharmaceutical company Ovid Therapeutics Inc. (NASDAQ: OVID) is on an uptick in early trades today. The stock was at a rise of +47.13% to $4.36 as of 11:09 a.m. EST followed by news of a global rights deal struck by the company.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What does the deal say?

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Ovid Therapeutics Inc. is a New York-based biopharmaceutical company that is transforming the lives of patients with rare neurological disorders developing treatments through its BoldMedicine approach.

Read More

There are many potential first-in-class medicines in the pipeline at Ovid.

Angelman syndrome, Fragile X syndrome, and rare epilepsies are among these programs, as are programs targeting other monogenetic disorders, which are in their early stages.

Announced today is a new exclusive agreement has been concluded between Takeda Pharmaceutical Company Limited (NYSE:TAK) and Ovid.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

Exit mobile version